Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery

PHASE2RecruitingINTERVENTIONAL
Enrollment

164

Participants

Timeline

Start Date

May 7, 2021

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Intrahepatic Cholangiocarcinoma
Interventions
DRUG

Gemcitabine

See arm for details.

DRUG

Oxaliplatin

See arm for details.

DRUG

Dexamethasone

See arm for details.

DRUG

Floxuridine (FUDR)

See arm for details.

DEVICE

Implanted Medical Device

Implanted hepatic arterial infusion pump by surgical oncology, to deliver HAI therapy

Trial Locations (11)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

10604

RECRUITING

Memorial Sloan Kettering Westchester - Limited Protocol Activities, Harrison

11553

RECRUITING

Memorial Sloan Kettering Nassau - Limited Protocol Activities, Uniondale

11725

RECRUITING

Memorial Sloan Kettering Commack - Limited Protocol Activities, Commack

20824

RECRUITING

National Heart, Lung, and Blood Institute (NIH) (Data Collection Only), Bethesda

27710

RECRUITING

Duke University (Data Collection Only), Durham

63110

RECRUITING

Washington University (Data Collection Only), St Louis

07920

RECRUITING

Memorial Sloan Kettering Basking Ridge - Limited Protocol Activities, Basking Ridge

07748

RECRUITING

Memorial Sloan Kettering Monmouth - Limited Protocol Activities, Middletown

07645

RECRUITING

Memorial Sloan Kettering Bergen - Limited Protocol Activities, Montvale

3015 GD

RECRUITING

Erasmus University (Data Collection Only), Rotterdam

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER